In addition to the well-known mutations in ion channels, GABARs and NMDARs, several genes involved in epilepsy have been identified as risk factors for neurodevelopmental and neurodegenerative disorders [12], including genes controlling cellular metabolism (such as SLC2A1, EPM2A, EPM2B, TPP1, ALDH7A1) and signaling pathways (such as MTOR, AKT3, PIK3CA, TSC1, TSC2, PTEN, DEPDC5, NPRL2, NPRL3) [13]. The gene discussed is SLC2A1; the disease is epilepsy.